Continued momentum with Q2 invoiced sales of NZ$14.1M

Q2 Financial Highlights:

• Total invoices sales and orders for the quarter were NZ$14.1M  *(1) ;

• Cash at bank of NZ$7.3M with an additional positive net receivables/payables (unaudited) balance of NZ$1.8M, which will bring the bank balance to NZ$9.1M;

• Inventories of NZ$14.4M (unaudited) to meet current demand are being maintained. Zoono is holding stock across several global locations to enable timely delivery, including USA, UK, China, Australia and MENA regions;

• Total cash receipts from customers NZ$20.5M for the six months to date (unaudited).

*(1) Zoono refers to “invoiced sales” when an order is received from a customer. A sale is only recorded as revenue once the product is despatched to the customer. Additional revenue from this quarter’s sales will be seen later this year once the orders has been dispatched.

Disc: I hold

Company Update Highlights:

• Further testing in the UAE reconfirms Zoono surface spray efficacy at 30 days

• Two new distribution/supply agreements signed

• Combined revenue targets are for NZ$23.0m for year 1, NZ$31.0m for year 2 and NZ$39.95m for year three

• Regulatory approvals received for Russia

• New Zoono treated face mask launched

Disc : I hold ZNO